Follow

"concerned about premature application in humans based on findings in mice, the US Food and Drug Administration cautioned against young plasma transfusions, noting that they have “no proven clinical benefit” for age-related or other diseases in humans. The same day the FDA released its statement, Ambrosia announced it would stop its transfusions. Now, the start-up has completely closed shop, Business Insider reports."

web.archive.org/web/2024011105

I am lazy
please cite source that Jews were involved

· · Web · 0 · 0 · 0
Sign in to participate in the conversation
Merovingian Club

A club for red-pilled exiles.